| Literature DB >> 27601382 |
Cassandra D Kelly-Cirino1, Patricia S Curry2, Jamie L Marola3, Niels K Helstrom4, Max Salfinger5.
Abstract
OMNIgene®•SPUTUM (OM-S) is a sputum transport reagent designed to work with all tuberculosis diagnostics and eliminate the need for cold chain. The aim of this preliminary study was to assess the compatibility of OM-S-treated sputum with the Xpert® MTB/RIF assay. Fifty-five characterized sputa from the FIND TB Specimen Bank were used. Compatibility of OM-S was assessed for both Xpert sample preparation methods: H.1 protocol (sediment, n=25) and H.2 protocol (direct expectorate, n=30). All controls were prepared using the H.2 protocol. Results revealed 100% concordance of MTB/RIF results for all except the low-positive group in the H.1 study arm (n=10; 88% concordance). OM-S-treated sputa were successful in both protocols; if the Xpert buffer is not added during the H.2 procedure, sample viscosity may require repeat testing. Using OM-S could offer users flexibility in clinical testing algorithms. Larger compatibility studies are warranted, particularly with respect to MTB/RIF results for low-positive samples.Entities:
Keywords: Cepheid® GeneXpert®; OMNIgene®•SPUTUM; TB diagnostics; Xpert® MTB/RIF assay; centralized testing; sputum transport
Mesh:
Substances:
Year: 2016 PMID: 27601382 DOI: 10.1016/j.diagmicrobio.2016.08.013
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN: 0732-8893 Impact factor: 2.803